{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:34:23Z","timestamp":1761676463882,"version":"build-2065373602"},"reference-count":84,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.sapharm.2016.11.005","type":"journal-article","created":{"date-parts":[[2016,11,15]],"date-time":"2016-11-15T18:54:40Z","timestamp":1479236080000},"page":"1055-1061","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: A latent class analysis"],"prefix":"10.1016","volume":"13","author":[{"given":"Gerald","family":"Cochran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Hruschak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer L.","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth C.","family":"Hohmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph","family":"Tarter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.sapharm.2016.11.005_bib1","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1177\/0897190014522064","article-title":"Pharmacists who screen and discuss opioid misuse with patients: future directions for research and practice","volume":"28","author":"Cochran","year":"2015","journal-title":"J\u00a0Pharm Pract"},{"issue":"2","key":"10.1016\/j.sapharm.2016.11.005_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jphs.12013","article-title":"Pharmacists' knowledge, attitudes and beliefs regarding screening and brief intervention for prescription opioid abuse: a survey of Utah and Texas pharmacists","volume":"4","author":"Cochran","year":"2013","journal-title":"J\u00a0Pharm Health Serv Res"},{"key":"10.1016\/j.sapharm.2016.11.005_bib3","doi-asserted-by":"crossref","unstructured":"Cochran G, Gordon AJ, Field C, et\u00a0al. Developing a framework of care for opioid medication misuse in community pharmacy. Res Soc Adm Pharm 12(2):293\u2013301.","DOI":"10.1016\/j.sapharm.2015.05.001"},{"year":"2015","series-title":"Actions of the 2015 APhA House of Delegates","author":"American Pharmacists Association","key":"10.1016\/j.sapharm.2016.11.005_bib4"},{"year":"2015","series-title":"American Pharmacists Association Policy Manual","author":"American Pharmacists Association","key":"10.1016\/j.sapharm.2016.11.005_bib5"},{"year":"2015","series-title":"American Society of Health-System Pharmacists Statement on the Pharmacist's Role in Substance Abuse Prevention, Education, and Assisstance","author":"American Society of Health-System Pharmacists","key":"10.1016\/j.sapharm.2016.11.005_bib6"},{"year":"2015","series-title":"Combating Opioid Drug Abuse with Naloxone","author":"Robinson","key":"10.1016\/j.sapharm.2016.11.005_bib7"},{"issue":"5","key":"10.1016\/j.sapharm.2016.11.005_bib8","first-page":"411","article-title":"Screening community pharmacy patients for risk of prescription opioid misuse","volume":"9","author":"Cochran","year":"2015","journal-title":"J\u00a0Addict Med"},{"year":"2011","series-title":"Epidemic: Responding to America's Prescription Drug Abuse Crisis","author":"Office of National Drug Congrol Policy","key":"10.1016\/j.sapharm.2016.11.005_bib9"},{"year":"2015","series-title":"Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health","author":"Substance Abuse and Mental Health Services Administration","key":"10.1016\/j.sapharm.2016.11.005_bib10"},{"year":"2015","author":"Centers for Disease Control and Prevention","key":"10.1016\/j.sapharm.2016.11.005_bib11"},{"year":"2016","series-title":"Drug Overdose Deaths in the United States Hit Record Numbers in 2014","author":"Centers for Disease Control and Prevention","key":"10.1016\/j.sapharm.2016.11.005_bib12"},{"key":"10.1016\/j.sapharm.2016.11.005_bib13","article-title":"An examination of claims-based predictors of overdose from a large medicaid program","author":"Cochran","year":"2016","journal-title":"Med Care"},{"issue":"9","key":"10.1016\/j.sapharm.2016.11.005_bib14","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1111\/j.1526-4637.2012.01450.x","article-title":"A\u00a0model to identify patients at risk for prescription opioid abuse, dependence, and misuse","volume":"13","author":"Rice","year":"2012","journal-title":"Pain Med"},{"issue":"2","key":"10.1016\/j.sapharm.2016.11.005_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054496","article-title":"Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993-2009","volume":"8","author":"Unick","year":"2013","journal-title":"PLos One"},{"issue":"2","key":"10.1016\/j.sapharm.2016.11.005_bib16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.pain.2010.05.020","article-title":"Risks for possible and probable opioid misuse among recipients of chronic opioid therapy in commercial and medicaid insurance plans: the TROUP Study","volume":"150","author":"Sullivan","year":"2010","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.sapharm.2016.11.005_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.drugalcdep.2007.09.018","article-title":"Non-medical use, abuse and dependence on prescription opioids among U.S. adults: psychiatric, medical and substance use correlates","volume":"94","author":"Becker","year":"2008","journal-title":"Drug Alcohol Depend"},{"issue":"12","key":"10.1016\/j.sapharm.2016.11.005_bib18","first-page":"897","article-title":"Analytic models to identify patients at risk for prescription opioid abuse","volume":"15","author":"White","year":"2009","journal-title":"Am J Manag Care"},{"issue":"8","key":"10.1016\/j.sapharm.2016.11.005_bib19","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1177\/070674371105600808","article-title":"Nonmedical prescription opioid use and mental health and pain comorbidities: a narrative review","volume":"56","author":"Amari","year":"2011","journal-title":"Can J Psychiatry"},{"issue":"7","key":"10.1016\/j.sapharm.2016.11.005_bib20","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.4088\/JCP.v67n0708","article-title":"Prevalence, correlates, and comorbidity of nonmedical prescription drug use and drug use disorders in the United States: results of the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"67","author":"Huang","year":"2006","journal-title":"J\u00a0Clin Psychiatry"},{"issue":"1-2","key":"10.1016\/j.sapharm.2016.11.005_bib21","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.drugalcdep.2009.01.019","article-title":"Pathways between nonmedical opioid use\/dependence and psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions","volume":"103","author":"Martins","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"1-2","key":"10.1016\/j.sapharm.2016.11.005_bib22","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.drugalcdep.2008.09.013","article-title":"Physical pain, common psychiatric and substance use disorders, and the non-medical use of prescription analgesics in the United States","volume":"100","author":"Novak","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"10","key":"10.1016\/j.sapharm.2016.11.005_bib23","first-page":"729","article-title":"Screening for potential prescription opioid misuse in a Michigan medicaid population","volume":"41","author":"Braker","year":"2009","journal-title":"Fam Med"},{"issue":"3","key":"10.1016\/j.sapharm.2016.11.005_bib24","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jpainsymman.2007.10.003","article-title":"Epidemiology of regular prescribed opioid use: results from a national, population-based survey","volume":"36","author":"Hudson","year":"2008","journal-title":"J\u00a0Pain Symptom Manag"},{"issue":"1","key":"10.1016\/j.sapharm.2016.11.005_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0018326","article-title":"The epistemology of mathematical and statistical modeling: a quiet methodological revolution","volume":"65","author":"Lee","year":"2010","journal-title":"Am Psychol"},{"issue":"6","key":"10.1016\/j.sapharm.2016.11.005_bib26","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.addbeh.2006.03.026","article-title":"Item response mixture modeling: application to tobacco dependence criteria","volume":"31","author":"Muthen","year":"2006","journal-title":"Addict Behav"},{"year":"2010","series-title":"Latent Class and Latent Transition Analysis : With Applications in the Social, Behavioral, and Health Sciences","author":"Collins","key":"10.1016\/j.sapharm.2016.11.005_bib27"},{"year":"2010","series-title":"Principles and Practice of Structural Equation Modeling","author":"Kline","key":"10.1016\/j.sapharm.2016.11.005_bib28"},{"year":"1987","series-title":"Latent Class Analysis","author":"McCutcheon","key":"10.1016\/j.sapharm.2016.11.005_bib29"},{"year":"2010","series-title":"Mplus Users Guide","author":"Muth\u00e9n","key":"10.1016\/j.sapharm.2016.11.005_bib30"},{"issue":"4","key":"10.1016\/j.sapharm.2016.11.005_bib31","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/10705510701575602","article-title":"PROC LCA: a SAS procedure for latent class analysis","volume":"14","author":"Lanza","year":"2007","journal-title":"Struct Equ Model"},{"issue":"1","key":"10.1016\/j.sapharm.2016.11.005_bib32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/ab.20370","article-title":"Risk and protective factors associated with patterns of antisocial behavior among nonmetropolitan adolescents","volume":"37","author":"Connell","year":"2011","journal-title":"Aggress Behav"},{"key":"10.1016\/j.sapharm.2016.11.005_bib33","unstructured":"[Blinded for review]."},{"issue":"7","key":"10.1016\/j.sapharm.2016.11.005_bib34","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1111\/j.1530-0277.2007.00403.x","article-title":"AUDIT-C as a brief screen for alcohol misuse in primary care","volume":"31","author":"Bradley","year":"2007","journal-title":"Alcohol Clin Exp Res"},{"issue":"9","key":"10.1016\/j.sapharm.2016.11.005_bib35","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/j.1530-0277.2012.01761.x","article-title":"Variation in documented care for unhealthy alcohol consumption across race\/ethnicity in the Department of Veterans Affairs Healthcare System","volume":"36","author":"Williams","year":"2012","journal-title":"Alcohol Clin Exp Res"},{"issue":"16","key":"10.1016\/j.sapharm.2016.11.005_bib36","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1001\/archinte.158.16.1789","article-title":"The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test","volume":"158","author":"Bush","year":"1998","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1016\/j.sapharm.2016.11.005_bib37","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jsat.2006.08.002","article-title":"A\u00a0comprehensive review of the psychometric properties of the Drug Abuse Screening Test","volume":"32","author":"Yudko","year":"2007","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"11","key":"10.1016\/j.sapharm.2016.11.005_bib38","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","article-title":"The patient health Questionnaire-2: validity of a two-item depression screener","volume":"41","author":"Kroenke","year":"2003","journal-title":"Med Care"},{"issue":"11 Pt 2","key":"10.1016\/j.sapharm.2016.11.005_bib39","first-page":"839","article-title":"Screening for depression and suicidality in a VA primary care setting: 2 items are better than 1 item","volume":"10","author":"Corson","year":"2004","journal-title":"Am J Manag Care"},{"issue":"2","key":"10.1016\/j.sapharm.2016.11.005_bib40","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jsat.2010.05.005","article-title":"Validation of the Primary Care Posttraumatic Stress Disorder screening questionnaire (PC-PTSD) in civilian substance use disorder patients","volume":"39","author":"van Dam","year":"2010","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"2","key":"10.1016\/j.sapharm.2016.11.005_bib41","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.janxdis.2007.02.010","article-title":"Identifying PTSD in primary care: comparison of the primary care-PTSD screen (PC-PTSD) and the general health questionnaire-12 (GHQ)","volume":"22","author":"Ouimette","year":"2008","journal-title":"J\u00a0Anxiety Disord"},{"key":"10.1016\/j.sapharm.2016.11.005_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1185\/135525703125002360","article-title":"The primary care PTSD screen (PC-PTSD): development and operating characteristics","volume":"9","author":"Prins","year":"2003","journal-title":"Prim Care Psychiatry"},{"issue":"3","key":"10.1016\/j.sapharm.2016.11.005_bib43","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/j.1365-2753.2010.01623.x","article-title":"Construct validity of the SF-12 in three different samples","volume":"18","author":"Jakobsson","year":"2012","journal-title":"J\u00a0Eval Clin Pract"},{"year":"2009","series-title":"A\u00a0Guide to the Integration of Certified Short Form Survey Scoring and Data Quality Evaluation Capabilities","author":"Maruish","key":"10.1016\/j.sapharm.2016.11.005_bib44"},{"issue":"4","key":"10.1016\/j.sapharm.2016.11.005_bib45","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.jsat.2008.02.001","article-title":"Prescription Opioid Misuse Index: a brief questionnaire to assess misuse","volume":"35","author":"Knisely","year":"2008","journal-title":"J\u00a0Subst Abuse Treat"},{"issue":"6","key":"10.1016\/j.sapharm.2016.11.005_bib46","doi-asserted-by":"crossref","first-page":"829","DOI":"10.15288\/jsad.2009.70.829","article-title":"Alcohol use among older adults in the national epidemiologic survey on alcohol and related conditions: a latent class analysis","volume":"70","author":"Sacco","year":"2009","journal-title":"J\u00a0Stud Alcohol Drugs"},{"issue":"3","key":"10.1016\/j.sapharm.2016.11.005_bib47","doi-asserted-by":"crossref","first-page":"449","DOI":"10.15288\/jsad.2008.69.449","article-title":"Service needs of clients in outpatient substance-use disorder treatment: a latent class analysis","volume":"69","author":"Perron","year":"2008","journal-title":"J\u00a0Stud Alcohol Drugs"},{"issue":"4","key":"10.1016\/j.sapharm.2016.11.005_bib48","doi-asserted-by":"crossref","first-page":"561","DOI":"10.15288\/jsad.2008.69.561","article-title":"Characteristics of individuals screening positive for substance use in a welfare setting: implications for welfare and substance-use disorders treatment systems","volume":"69","author":"Morgenstern","year":"2008","journal-title":"J\u00a0Stud Alcohol Drugs"},{"issue":"4","key":"10.1016\/j.sapharm.2016.11.005_bib49","doi-asserted-by":"crossref","first-page":"552","DOI":"10.15288\/jsa.2006.67.552","article-title":"A\u00a0Mixture Model of Discontinuous Development in Heavy Drinking From Ages 18 to 30: The Role of College Enrollment","volume":"67","author":"Lanza","year":"2006","journal-title":"J\u00a0Stud Alcohol."},{"issue":"6","key":"10.1016\/j.sapharm.2016.11.005_bib50","doi-asserted-by":"crossref","first-page":"943","DOI":"10.15288\/jsad.2009.70.943","article-title":"A\u00a0multiprocess latent class analysis of the co-occurrence of substance use and sexual risk behavior among adolescents","volume":"70","author":"Connell","year":"2009","journal-title":"J\u00a0Stud Alcohol Drugs"},{"issue":"5","key":"10.1016\/j.sapharm.2016.11.005_bib51","doi-asserted-by":"crossref","first-page":"738","DOI":"10.15288\/jsad.2008.69.738","article-title":"Social support and cognitive impairment in clients receiving treatment for alcohol- and drug-use disorders: a replication study","volume":"69","author":"Buckman","year":"2008","journal-title":"J\u00a0Stud Alcohol Drugs"},{"issue":"3","key":"10.1016\/j.sapharm.2016.11.005_bib52","doi-asserted-by":"crossref","first-page":"420","DOI":"10.15288\/jsad.2008.69.420","article-title":"Concurrent change in alcohol and drug problems among treated adolescents over three years","volume":"69","author":"Chung","year":"2008","journal-title":"J\u00a0Stud Alcohol Drugs"},{"issue":"1","key":"10.1016\/j.sapharm.2016.11.005_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0191-8869(95)00045-8","article-title":"Latent class analysis applied to health behaviours","volume":"19","author":"Ingledew","year":"1995","journal-title":"Pers Individ Dif"},{"issue":"3","key":"10.1016\/j.sapharm.2016.11.005_bib54","first-page":"215","article-title":"Making sense of symptom checklists: a latent class approach to the first 9 years of the British Household Panel Survey","volume":"25","author":"Sacker","year":"2003","journal-title":"J\u00a0Public Health Med"},{"issue":"2","key":"10.1016\/j.sapharm.2016.11.005_bib55","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1475-6773.2010.01210.x","article-title":"Psychometric properties of the patient activation measure among multimorbid older adults","volume":"46","author":"Skolasky","year":"2011","journal-title":"Health Serv Res"},{"issue":"1","key":"10.1016\/j.sapharm.2016.11.005_bib56","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1080\/15017410701469231","article-title":"Older people and dissatisfaction with wheelchair services","volume":"10","author":"Stewart","year":"2008","journal-title":"Scand J Disabil Res"},{"issue":"1","key":"10.1016\/j.sapharm.2016.11.005_bib57","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/YIC.0b013e3283400cb2","article-title":"Pharmacoepidemiological characterization of psychotropic drugs consumption using a latent class analysis","volume":"26","author":"Wainstein","year":"2011","journal-title":"Int Clin Psychopharmacol"},{"issue":"7","key":"10.1016\/j.sapharm.2016.11.005_bib58","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1017\/S0007114510004745","article-title":"Investigation of population heterogeneity of diet use among middle-aged Australians","volume":"105","author":"Wang","year":"2011","journal-title":"Br J Nutr"},{"issue":"1","key":"10.1016\/j.sapharm.2016.11.005_bib59","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.healthplace.2010.11.002","article-title":"Neighborhood archetypes for population health research: is there no place like home?","volume":"17","author":"Weden","year":"2011","journal-title":"Health Place"},{"issue":"3","key":"10.1016\/j.sapharm.2016.11.005_bib60","doi-asserted-by":"crossref","first-page":"464","DOI":"10.15288\/jsad.2016.77.464","article-title":"Longitudinal effects of early childhood maltreatment on Co-Occurring substance misuse and mental health problems in adulthood: the role of adolescent alcohol use and depression","volume":"77","author":"Skinner","year":"2016","journal-title":"J\u00a0Stud Alcohol Drugs"},{"key":"10.1016\/j.sapharm.2016.11.005_bib61","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.janxdis.2016.04.002","article-title":"Interpersonal polyvictimization and mental health in males","volume":"40","author":"Burns","year":"2016","journal-title":"J\u00a0Anxiety Disord"},{"issue":"5","key":"10.1016\/j.sapharm.2016.11.005_bib62","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s10802-015-0086-8","article-title":"Developmental patterns of adverse childhood experiences and current symptoms and impairment in youth referred for trauma-specific services","volume":"44","author":"Grasso","year":"2016","journal-title":"J\u00a0Abnorm Child Psychol"},{"key":"10.1016\/j.sapharm.2016.11.005_bib63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jad.2016.04.010","article-title":"The structure and intensity of self-reported autonomic arousal symptoms across anxiety disorders and obsessive-compulsive disorder","volume":"199","author":"Berle","year":"2016","journal-title":"J\u00a0Affect Disord"},{"issue":"4","key":"10.1016\/j.sapharm.2016.11.005_bib64","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10705510701575396","article-title":"Deciding on the number of classes in latent class analysis and growth mixture modeling: a monte carlo simulation study","volume":"14","author":"Nylund","year":"2007","journal-title":"Struct Equ Model"},{"issue":"8","key":"10.1016\/j.sapharm.2016.11.005_bib65","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/cncr.23815","article-title":"Patient navigation: state of the art or is it science?","volume":"113","author":"Wells","year":"2008","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.sapharm.2016.11.005_bib66","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1037\/1082-989X.2.4.371","article-title":"General longitudinal modeling of individual differences in experimental designs: a latent variable framework for analysis and power estimation","volume":"2","author":"Muthen","year":"1997","journal-title":"Psychol Methods"},{"issue":"2","key":"10.1016\/j.sapharm.2016.11.005_bib67","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s11121-011-0201-1","article-title":"Latent class analysis: an alternative perspective on subgroup analysis in prevention and treatment","volume":"14","author":"Lanza","year":"2013","journal-title":"Prev Sci"},{"year":"2003","series-title":"Relating Latent Class Analysis Results to Variables Not Included in the Analysis","author":"Clark","key":"10.1016\/j.sapharm.2016.11.005_bib68"},{"year":"2014","series-title":"Auxiliary Variables in Mixture Modeling: 3-Step Approaches Using Mplus","author":"Asparouhov","key":"10.1016\/j.sapharm.2016.11.005_bib69"},{"year":"2013","series-title":"Mplus 7.11 [computer Program]. Version 6","key":"10.1016\/j.sapharm.2016.11.005_bib70"},{"issue":"16","key":"10.1016\/j.sapharm.2016.11.005_bib71","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/ajhp\/55.16.1721","article-title":"ASHP statement on the pharmacist's role in substance abuse prevention, education, and assistance","volume":"55","author":"Baldwin","year":"1998","journal-title":"Am Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2016.11.005_bib72","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.1331\/JAPhA.2014.13101","article-title":"Pharmacists' role in addressing opioid abuse, addiction, and diversion","volume":"54","author":"Association AP","year":"2014","journal-title":"J\u00a0Am Pharm Assoc"},{"year":"2008","series-title":"Integration of mental health\/substance abuse and primary care","author":"Butler","key":"10.1016\/j.sapharm.2016.11.005_bib73"},{"issue":"6","key":"10.1016\/j.sapharm.2016.11.005_bib74","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"issue":"1","key":"10.1016\/j.sapharm.2016.11.005_bib75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pain.2004.07.026","article-title":"Validation of a screener and opioid assessment measure for patients with chronic pain","volume":"112","author":"Butler","year":"2004","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.sapharm.2016.11.005_bib76","doi-asserted-by":"crossref","first-page":"353","DOI":"10.5055\/jom.2014.0226","article-title":"Further validation of an opioid risk assessment tool: the Brief Risk Interview","volume":"10","author":"Jones","year":"2014","journal-title":"J\u00a0Opioid Manag"},{"issue":"15","key":"10.1016\/j.sapharm.2016.11.005_bib77","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1001\/jama.2016.1464","article-title":"CDC guideline for prescribing opioids for chronic pain\u2014United States, 2016","volume":"315","author":"Dowell","year":"2016","journal-title":"JAMA"},{"issue":"18","key":"10.1016\/j.sapharm.2016.11.005_bib78","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2146\/ajhp140157","article-title":"The opioid abuse and misuse epidemic: implications for pharmacists in hospitals and health systems","volume":"71","author":"Cobaugh","year":"2014","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2016.11.005_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-7517-1-3","article-title":"Substance abuse and pharmacy practice: what the community pharmacist needs to know about drug abuse and dependence","volume":"1","author":"Tommasello","year":"2004","journal-title":"Harm Reduct J"},{"issue":"9","key":"10.1016\/j.sapharm.2016.11.005_bib80","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s11606-010-1377-y","article-title":"The Physician Clinical Support System-Buprenorphine (PCSS-B): a novel project to expand\/improve buprenorphine treatment","volume":"25","author":"Egan","year":"2010","journal-title":"J\u00a0Gen Intern Med"},{"key":"10.1016\/j.sapharm.2016.11.005_bib81","unstructured":"Substance Abuse and Mental Health Services Administration. Buprenorphine Treatment Physician Locator at http:\/\/www.samhsa.gov\/medication-assisted-treatment\/physician-program-data\/treatment-physician-locator, August 23, 2016."},{"year":"2016","series-title":"Tools and Guidelines - Opioid Use","author":"American Pharmacists Association","key":"10.1016\/j.sapharm.2016.11.005_bib82"},{"issue":"6","key":"10.1016\/j.sapharm.2016.11.005_bib83","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1331\/JAPhA.2014.14034","article-title":"Implementation of targeted medication adherence interventions within a community chain pharmacy practice: the Pennsylvania Project","volume":"54","author":"Bacci","year":"2014","journal-title":"J\u00a0Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.sapharm.2016.11.005_bib84","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12954-015-0058-x","article-title":"Orienting patients to greater opioid safety: models of community pharmacy-based naloxone","volume":"12","author":"Green","year":"2015","journal-title":"Harm Reduct J"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741116305654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741116305654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T09:12:06Z","timestamp":1761556326000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741116305654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S1551741116305654"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2016.11.005","relation":{},"ISSN":["1551-7411"],"issn-type":[{"type":"print","value":"1551-7411"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Behavioral, mental, and physical health characteristics and opioid medication misuse among community pharmacy patients: A latent class analysis","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2016.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}